Global hepatitis C elimination: an investment framework

Area of Science:

• Public Health
• Health Economics
• Infectious Disease Control

Background:

• The World Health Organization (WHO) has established global targets for eliminating hepatitis B and C by 2030.
• Current investment in hepatitis elimination programs is insufficient to meet these targets.
• A significant gap exists in political commitment and financing for national hepatitis control strategies.

Purpose of the Study:

• To present a global investment framework to drive political commitment and financing for hepatitis B and C elimination.
• To outline national and international activities crucial for reducing hepatitis C incidence and mortality.
• To identify funding sources and economic tools to support country-level investment in hepatitis elimination.

Main Methods:

• Development of a comprehensive global investment framework for hepatitis elimination.
• Analysis of potential funding sources and economic justification for investment.
• Identification of key national and international activities for disease reduction.

Main Results:

• The framework provides a strategic approach for countries to invest in hepatitis elimination.
• It highlights the substantial economic benefits and cost savings associated with hepatitis C elimination.
• The framework offers tools to build a strong economic case for national hepatitis elimination initiatives.

Conclusions:

• Investing in hepatitis C elimination yields significant economic advantages and cost savings, particularly for resource-limited nations.
• The developed framework can catalyze the necessary political will and financial resources for achieving global hepatitis elimination targets.
• Enhanced investment is critical to realizing the WHO's 2030 goals for hepatitis B and C elimination.